PAVmed Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PAVmed Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • PAVmed Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $93.6M, a 62.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $93.6M +$36.1M +62.8% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $57.5M +$13.1M +29.6% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $44.4M +$18.9M +74.5% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $25.4M +$8.72M +52.2% Dec 31, 2020 10-K 2022-04-06
Q4 2019 $16.7M +$8.15M +95.2% Dec 31, 2019 10-K 2021-03-15
Q4 2018 $8.56M +$4.82M +129% Dec 31, 2018 10-K 2020-04-14
Q4 2017 $3.74M +$6.9M Dec 31, 2017 10-K 2019-04-01
Q4 2016 -$3.16M Dec 31, 2016 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.